Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
Aikaterini Tsiogka, Maria Kyriazopoulou, George Kontochristopoulos, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4431-4431
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Oral Janus kinase inhibitors for atopic dermatitis
Daniela Mikhaylov, Benjamin Ungar, Yael Renert‐Yuval, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 5, pp. 577-592
Open Access | Times Cited: 34
Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
Karolina Makowska, Joanna Nowaczyk, Leszek Blicharz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 781-781
Open Access | Times Cited: 33
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
Helena Iznardo, Esther Roé, E. Serra‐Baldrich, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 385-385
Open Access | Times Cited: 20
A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
Mircea Tampa, Cristina Iulia Mitran, Mădălina Irina Mitran, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 384-384
Open Access | Times Cited: 18
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review
Aishwarya Muddebihal, Ananta Khurana, Kabir Sardana
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 279-295
Closed Access | Times Cited: 17
Protective effect of isoquercitrin on UVB‐induced injury in HaCaT cells and mice skin through anti‐inflammatory, antioxidant, and regulation of MAPK and JAK2‐STAT3 pathways
Yingyan Li, Yunge Ma, Yike Yao, et al.
Photochemistry and Photobiology (2024) Vol. 100, Iss. 5, pp. 1507-1518
Closed Access | Times Cited: 5
Pathogenesis and management of atopic dermatitis: insights into epidermal barrier dysfunction and immune mechanisms
Anurag T. K. Baidya, Ulaganathan Mabalirajan
(2025)
Open Access
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy
Mohamad Mahjoor, Golnaz Mahmoudvand, Simin Farokhi, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Epigenetic control of inflammation in Atopic Dermatitis
Sabah Akhtar, Reem Khaled M.E. Alsayed, Fareed Ahmad, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 199-207
Open Access | Times Cited: 12
T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
Chunjiao Zheng, Yuling Shi, Ying Zou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1303-1303
Open Access | Times Cited: 11
The Application of Drugs and Nano-Therapies Targeting Immune Cells in Hypoxic Inflammation
Jiaxin Luo, Hanchi Wang, Jingxia Chen, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3441-3459
Open Access | Times Cited: 3
Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression
Damián Sánchez-Ramírez, Mónica Mendoza-Rodríguez, Omar Rafael Alemán, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 5, pp. 1705-1724
Open Access | Times Cited: 2
Circadian rhythm of cutaneous pruritus.
Zichao Jiang, Xiaoxue Sang, Jianyun Lu, et al.
PubMed (2024) Vol. 49, Iss. 2, pp. 190-196
Closed Access | Times Cited: 2
Monotropein mitigates atopic dermatitis-like skin inflammation through JAK/STAT signaling pathway inhibition
In‐Young Yang, Na-Hee Jeong, Young‐Ae Choi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116911-116911
Open Access | Times Cited: 2
Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders
Mutong Zhao, Yi Zhuang, Yuan Liang, et al.
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 9, pp. 694-696
Closed Access | Times Cited: 2
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Devank Shekho, Ritika Mishra, Raj Kamal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 2
JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
Albertine Beard, Shannon C. Trotter
Journal of Family Medicine and Primary Care (2024) Vol. 13, Iss. 10, pp. 4128-4134
Open Access | Times Cited: 2
Unveiling abrocitinib: A thorough examination of the 2022 USFDA-approved treatment for atopic dermatitis (AD)
Daniela Bermeo Grajales, Nermala Sewdat, Ryan Leo, et al.
Medicine in Drug Discovery (2023) Vol. 20, pp. 100161-100161
Open Access | Times Cited: 7
Therapeutic effects and mechanisms of Ku-Gan formula on atopic dermatitis: A pilot clinical study and modular pharmacology analysis with animal validation
Xin Ma, Le Kuai, Jiankun Song, et al.
Journal of Ethnopharmacology (2023) Vol. 307, pp. 116194-116194
Closed Access | Times Cited: 6
Naringenin ameliorates atopic dermatitis by inhibiting inflammation and enhancing immunity through the JAK2/STAT3 pathway
Limin Tian, Mengjie Wang, Yangxingyun Wang, et al.
Genes & Genomics (2023) Vol. 46, Iss. 3, pp. 333-340
Closed Access | Times Cited: 6
The relationship between umbilical cord blood IL-22 level and infantile eczema at 42 days
Xujun Lu, Wenge Wang, Yang Wang, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1
Concurrent Refractory Atopic Dermatitis and Generalized Vitiligo Successfully Treated with Abrocitinib: A Case Report
Xinyi Shao, Xingyu Pan, Yangmei Chen, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 1259-1263
Open Access | Times Cited: 1
PCSK9 in T-cell function and the immune response
Yuying Wang, Xiaosheng Fang, Jiarui Liu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top